98%
921
2 minutes
20
Background: A novel ready-to-use microbiome-directed food (MDF) has been developed for the management of acute malnutrition using ingredients that promote repair of the gut microbiota of undernourished children.
Objectives: This study aims to assess the acceptability of MDF compared with standard nutritional care among children with acute malnutrition.
Methods: Two randomized crossover trials consisting of 2 14-d periods of at-home consumption were conducted. Children aged 6 to <24 mo with severe acute malnutrition (SAM) or moderate acute malnutrition (MAM) were individually randomized in a 1:1 ratio to the sequence of receiving MDF then standard nutritional care, or vice versa. Standard nutritional care consisted of ready-to-use therapeutic food for SAM and ready-to-use supplementary food for MAM. The primary outcome was at-home acceptability, defined as the return of ≥75% of sachets empty after the 14-d at-home consumption period. The primary analysis was a noninferiority analysis, in which MDF was considered noninferior if the lower bound of the 95% confidence interval (CI) of the difference in at-home acceptability comparing MDF with standard nutritional care was within -20 percentage points. Secondary outcomes included caregiver's perception of the child's liking, as well as caregiver willingness to use in the future and preference between the 2 foods.
Results: In all, 128 children with SAM and 146 children with MAM were randomized. MDF was noninferior to standard nutritional care in terms of at-home acceptability among children with SAM (risk difference: -7.0; 95% CI lower bound: -11.6%) and among children with MAM (risk difference: -2.3%; 95% CI lower bound: -6.1%). There were no differences in caregiver willingness to use either food in future.
Conclusions: MDF is acceptable for the management of acute malnutrition in children aged 6 to <24 mo in Niger and should be further tested in other populations with a high prevalence of acute malnutrition. Effectiveness of the novel food will be assessed in forthcoming trials.
Trial Registration Number: This trial was registered at clinicaltrials.gov as NCT05551819.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12266491 | PMC |
http://dx.doi.org/10.1016/j.cdnut.2025.107484 | DOI Listing |
Lancet Haematol
September 2025
Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia; School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia; Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australi
Expert Rev Gastroenterol Hepatol
September 2025
Medically Associated Science and Technology (MAST) Program, Cedars-Sinai, Los Angeles, CA, USA.
Introduction: Historically, irritable bowel syndrome (IBS) has been classified as a functional disorder, diagnosed through symptom-based criteria and managed by a uniform algorithm. However, current research suggests IBS may represent a group of disorders, each with an organic basis, such as post-infectious changes to the intestinal tract, inflammation, and immune activation, gut-brain axis dysfunction, bile acid dysregulation, or gut microbiome irregularities.
Areas Covered: This literature review examines the historical classification of IBS, the revisions/changes in diagnostic criteria over time, and innovative research into potential causes of the disease.
Curr Dev Nutr
July 2025
Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, United States.
Background: A novel ready-to-use microbiome-directed food (MDF) has been developed for the management of acute malnutrition using ingredients that promote repair of the gut microbiota of undernourished children.
Objectives: This study aims to assess the acceptability of MDF compared with standard nutritional care among children with acute malnutrition.
Methods: Two randomized crossover trials consisting of 2 14-d periods of at-home consumption were conducted.
Antonie Van Leeuwenhoek
June 2025
School of Life Science and Food Engineering, Huaiyin Institute of Technology, Huai'an, Jiangsu, 223003, People's Republic of China.
Fish spoilage is a microbially-mediated biochemical process resulting in quality deterioration, economic losses, and food safety risks. Studies have indicated that spoilage microbiota are phylogenetically diverse, with Gram-negative bacteria (Pseudomonas, Shewanella, Photobacterium) representing primary spoilage organisms, and Gram-positive bacteria (Lactobacillus, Brochothrix) causing spoilage only under specific conditions. Microorganisms cause spoilage through the utilization of three main metabolic processes: (i) proteolytic degradation of muscle proteins, (ii) lipolytic breakdown of triglycerides, and (iii) production of volatile bioactive organic compounds and biogenic amines.
View Article and Find Full Text PDFBMC Nutr
May 2025
Institut de Recherche en Sciences de la Santé (IRSS), National Centre for Scientific and Technologic Research (CNRST), Wemtenga, Rue 29, 39 Porte 74, 03 P.B. 7192, Ouagadougou, Burkina Faso.
Background: Acute malnutrition still affects millions of children under five years of age globally each year and contributes to approximately half of all annual childhood deaths. A considerable proportion of patients who recover from acute malnutrition experience poor health and nutrition and eventually relapse after they are discharged from community management of acute malnutrition programs. A microbiota-directed complementary food (MDCF) showed a superior effect compared to standard ready-to-use supplementary food (RUSF) in terms of ponderal growth and potential benefit for bacterial taxa that were correlated with weight-for-height z-score (WHZ).
View Article and Find Full Text PDF